Table: Zeria Pharm -2016/17 parent results
May 12 (Reuters)-
Zeria Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2017 Mar 31, 2016 Mar 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 47.41 48.27
(-1.8 pct) (-1.2 pct)
Operating 825 mln 1.39
(-40.5 pct) (+136.3 pct)
Recurring 1.93 2.59
(-25.4 pct) (+49.4 pct)
Net 2.34 2.60
(-9.9 pct) (+13.4 pct)
EPS 44.08 yen 48.93 yen
Ann Div 32.00 yen 31.00 yen 34.00 yen
-Q2 Div 16.00 yen 15.00 yen 17.00 yen
-Q4 Div 16.00 yen 16.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T
((Tokyo Headline News Desk +813 6441 1812))